FDA Advises on Clinical Trials for Uncomplicated UTI Treatments

Drug Industry Daily
A A
The FDA invited comments from stakeholders on a new draft guidance for clinical trial designs and drug development programs to support indications for uncomplicated urinary tract infection (uUTI) treatments.

To View This Article:

Login

Subscribe To Drug Industry Daily